Celltrion
068270.KS
$125.74
Share price
-2.37%
Change (1 day)
-3.22%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Operating Margin for Celltrion (068270.KS)
Operating Margin as of April 2024 (TTM): 30.17%
According to Celltrion 's latest financial reports and stock price the company's current Operating Margin is 30.17%. At the end of 2022 the company had an Operating Margin of 27.74%.
Operating Margin history for Celltrion from 2008 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 27.74% | -30.17% |
| 2021 | 39.73% | 10.54% |
| 2020 | 35.94% | 3.25% |
| 2019 | 34.81% | 8.06% |
| 2018 | 32.22% | -38.57% |
| 2017 | 52.44% | 44.47% |
| 2016 | 36.30% | 13.6% |
| 2015 | 31.96% | -19.7% |
| 2014 | 39.80% | -39.08% |
| 2013 | 65.33% | 11.94% |
| 2012 | 58.36% | -12.44% |
| 2011 | 66.65% | 8.72% |
| 2010 | 61.30% | 29.56% |
| 2009 | 47.32% | 63.37% |
| 2008 | 28.96% | 1066.02% |
| 2007 | 2.48% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.